openPR Logo
Press release

Antidepressant Drugs Market Size | COVID-19 Impact Analysis | Forecast to 2027

02-11-2022 07:56 AM CET | Health & Medicine

Press release from: Orion Market Research

The global antidepressant drug market is expected to grow at a significant CAGR during the forecast period. Antidepressants are used for the treatment of all age group patients suffering from clinical and anxiety depression and are further used for regulating mood. As per the Centers for Disease Control and Prevention (CDC), during the period, 2011–2014, 12.7% of people aged 12 and overtook antidepressant medication. This, in turn, reflects the increasing demand for antidepressant drugs in the market.

Based on the drug class, the antidepressant drugs market is segmented into selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), atypical antidepressants, monoamine oxidase inhibitors (MAOIs), and other medications. SSRIs segment held a significant share in the global antidepressant drug market.

To Request a Sample of our Report on Antidepressant Drugs Market: https://www.omrglobal.com/request-sample/antidepressant-drugs-market

SSRIs aim to relieve symptoms that work by blocking the reuptake, or reabsorption, of serotonin by some brain nerve cells. It increases the serotonin level in the brain, which improves mood. SSRIs drugs include sertraline, escitalopram, citalopram, fluoxetine, and paroxetine, usually produced at least side effects, as compared to tricyclic antidepressants. The common side effects of these drugs comprise sexual dysfunction, sleepiness or insomnia, and weight gain. These types of drugs are considered a potential treatment for all kinds of anxiety disorders; however, the treatment of OCD normally requires higher doses.

SNRIs class include duloxetine and venlafaxine, which is known for its dual mechanism of action, such as enhancing the levels of the norepinephrine and neurotransmitters serotonin by constraining their reabsorption into brain cells. Like other medications, its possible side effects include a minor increase in blood pressure, headache, stomach upset, insomnia, sexual dysfunction, and weight gain. Such medications are considered as potential as SSRIs, and therefore, it is also considered as a first-line treatment to treat anxiety disorders. However, it is not preferred for OCD, where SSRIs are usually chosen as a first-line treatment.

However, antidepressants may trigger hypomania or mania in some people. If the patient stops taking the antidepressant, it can worsen bipolar symptoms. In this case, the patient may be given a new diagnosis and different medication. Several other side-effects that are associated with antidepressants include neuroleptic malignant syndrome, suicidal feelings, SIADH (Syndrome of Inappropriate Antidiuretic Hormone Secretion), and serotonin syndrome. Due to these concerns, major pharmaceutical companies, including GSK, AstraZeneca, Pfizer, Merck, and Sanofi slowed researches on new antidepressants altogether. This, in turn, results in slowing down the adoption rate and the overall antidepressant drug market.

(Get 15% Discount on Buying this Report)

A full Report of Antidepressant Drugs Market is Available @ https://www.omrglobal.com/industry-reports/antidepressant-drugs-market

Global Antidepressant Drugs Market – Segmentation

By Depressive Disorder

· Major Depressive Disorder (MDD)

· Obsessive-compulsive Disorder (OCD)

· Generalized Anxiety Disorder (GAD)

· Panic Disorder (PD)

· Other Depressive Disorders

By Drug Class

· Selective Serotonin Reuptake Inhibitors (SSRIs)

· Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)

· Atypical Antidepressants

· Monoamine Oxidase Inhibitors (MAOIs)

· Other Medications

Global Antidepressant Drugs Market – Segmentation by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Company Profiles

· Alkermes Plc

· Allergan PLC

· Breckenridge Pharmaceutical, Inc.

· AstraZeneca Plc

· Bristol Myers Squibb Co.

· Camber Pharmaceutical Inc.

· Eli Lilly & Co.

· GlaxoSmithKline Plc

· H. Lundbeck A/S

· Intellipharmaceutics International Inc.

· Johnson & Johnson Services Inc.

· Merck & Co., Inc.

· Mylan N.V.

· Novartis International AG

· Pfizer Inc.

· Sanofi S.A.

· Sun Pharmaceuticals Ltd.

· Takeda Pharmaceutical Co.

· Teva Pharmaceutical Industries Ltd.

Reasons to buy from us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antidepressant Drugs Market Size | COVID-19 Impact Analysis | Forecast to 2027 here

News-ID: 2550227 • Views:

More Releases from Orion Market Research

Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, …
Infrastructure as Code (IaC) Service Market was valued at approximately USD 0.932 billion, and it's projected to expand to around USD 7.509 billion by 2033, achieving a robust CAGR of 23.2% from 2024 to 2033. Infrastructure as Code (IaC) Service Market Overview The Infrastructure as Code (IaC) Service Market is experiencing remarkable expansion, fueled by the escalating need for scalable, automated infrastructure deployment across cloud and enterprise environments. In 2023, the market
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to Understanding the Process
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to …
Ultra High‐Performance Liquid Chromatography (UHPLC) Columns Market is estimated to be valued at USD 2.5 billion, and is projected to grow to approximately USD 4.8 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.8% from 2024 to 2033. Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market Overview The UHPLC columns market is on a strong growth trajectory, fueled by increasing demand for rapid, high-resolution analytical techniques across pharmaceuticals, biotechnology,
Property Management Service Market Rising Demand and Growth Forecast Through 2033
Property Management Service Market Rising Demand and Growth Forecast Through 203 …
Property Management Service Market was valued at approximately USD 17.3 billion. It is anticipated to reach around USD 32.0 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2033. Property Management Service Market Overview The Property Management Service Market is witnessing steady growth due to increasing urbanization, rising investments in real estate, and a growing demand for outsourced property management solutions. Property owners are increasingly
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSilicon Technologies Co., Ltd., ZTE Corporation,
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSili …
The global 5G chipset market was valued at USD 33.75 billion in 2024 and is projected to reach USD 502.66 billion by 2033, growing at a compound annual growth rate (CAGR) of 35% from 2025 to 2033. 5G Chipset Market Overview The 5G chipset market is experiencing rapid growth, driven by the global rollout of 5G networks and the increasing demand for high-speed, low-latency connectivity across various applications, including smartphones, IoT

All 5 Releases


More Releases for SSRIs

Antidepressant Drugs Market is Dazzling Worldwide and Forecast to 2031
The global antidepressant drug market is expected to grow at a significant CAGR during the forecast period. Antidepressants are used for the treatment of all age group patients suffering from clinical and anxiety depression and are further used for regulating mood. As per the Centers for Disease Control and Prevention (CDC), during the period, 2011-2014, 12.7% of people aged 12 and overtook antidepressant medication. This, in turn, reflects the increasing
Selective Serotonin Reuptake Inhibitors Market - A new dawn for mental health: H …
Newark, New Castle, USA: The "Selective Serotonin Reuptake Inhibitors Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Selective Serotonin Reuptake Inhibitors Market: https://www.growthplusreports.com/report/selective-serotonin-reuptake-inhibitors-market/8781 This latest report researches the
Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Is Projected To Re …
Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Selective Serotonin Reuptake Inhibitors (SSRIs) estimated at US$ 4977 million in the year 2022, is projected to reach a revised size of US$ 6118 million by 2028, growing at a CAGR of 3.5% during the forecast period 2022-2028. With an increase in mental illnesses, there is a rising need for effective neurological drugs. Among the various neurological
Global Antidepressant Drugs Market Size, Share, Analysis, Industry Report and Fo …
The global antidepressant drug market is expected to grow at a significant CAGR during the forecast period. Antidepressants are used for the treatment of all age group patients suffering from clinical and anxiety depression and are further used for regulating mood. As per the Centers for Disease Control and Prevention (CDC), during the period, 2011–2014, 12.7% of people aged 12 and overtook antidepressant medication. This, in turn, reflects the increasing
Antidepressant Drugs Market Size, Share, Growth, Research and Forecast 2019-2025
The global antidepressant drug market is expected to grow at a significant CAGR during the forecast period. Antidepressants are used for the treatment of all age group patients suffering from clinical and anxiety depression and are further used for regulating mood. As per the Centers for Disease Control and Prevention (CDC), during the period, 2011–2014, 12.7% of people aged 12 and overtook antidepressant medication. This, in turn, reflects the increasing
Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size, Status and F …
Market Research Report Store offers a latest published report on Selective Serotonin Reuptake Inhibitors (SSRIs) Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Selective Serotonin Reuptake Inhibitors (SSRIs) players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Selective